GPAT3 and hepatocellular carcinoma: Analysis of the GEO database showed a 2-fold elevation in GPAT3 expression in xenografted tumor tissues with SR, but not in oxaliplatin and levantinib resistant HCC cells (Figure 2G, Figure S3C).